Status:
COMPLETED
Treatment of Hyperhidrosis With Oxybutynin
Lead Sponsor:
University Hospital, Brest
Collaborating Sponsors:
Ministry of Health, France
Conditions:
Hyperhidrosis
Eligibility:
All Genders
18+ years
Phase:
PHASE3
Brief Summary
Evaluation of the effectiveness of oxybutynin in hyperhidrosis
Eligibility Criteria
Inclusion
- Age greater than 18 years
- Patient affiliated to social security or beneficiary of such a regime
- Patient able to consent
- Patient with hyperhidrosis, generalized or localized (palmar, plantar, axillary) and whose score HDSS (Hyperidrosis Disease Severity Scale) is greater than two.
Exclusion
- Age less than 18 years
- Patient who can't be followed
- Patient participating in another clinical trial
- Pregnant
- Woman breastfeeding
- Hypersensitivity to oxybutynin or any of the excipients
- Risk of urinary retention related disorders uretroprostatiques
- Intestinal obstruction
- Toxic megacolon
- Intestinal atony
- Severe Ulcerative Colitis
- Myasthenia
- Closure glaucoma the anterior chamber angle or slightly deep
Key Trial Info
Start Date :
June 1 2013
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 1 2014
Estimated Enrollment :
62 Patients enrolled
Trial Details
Trial ID
NCT01855256
Start Date
June 1 2013
End Date
March 1 2014
Last Update
December 3 2025
Active Locations (4)
Enter a location and click search to find clinical trials sorted by distance.
1
CHG de Morlaix
Morlaix, France, France, 29600
2
Hospital, Brest
Brest, France, 29609
3
CHG Landerneau
Landerneau, France, 29800
4
Dermatologist'S Office
Quimper, France, 29000